in a prospective phase iii multicenter trial , 189 patients with advanced measurable and nonmeasurable gastric cancer were randomized to receive 5-fluorouracil ( 5-fu ) combined with adriamycin ( fa ) or fa plus methyl-ccnu ( mefa ) .
C0016360
5-fu
C0051571
mefa